Epitalon Peptide: A Complete Evidence-Based Guide

The peptide Epitalon, also referred to as Epithalon, is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly, written in single-letter code as AEDG. It contains four amino acid residues: alanine, glutamic acid, aspartic acid, and glycine. The primary structure is a linear peptide with unmodified amino and carboxyl termini. [1]

Similarity in names can lead to Epitalon being confused with Epithalamin. The first name refers to a specific tetrapeptide, and the second to a complex peptide preparation historically associated with pineal gland extracts. These are not synonyms.

In this article, we discuss the chemical identity of AEDG, how to read the sequence, the types of structural differences and the significance of analytical data. The description does not cover applications, dosage or product comparisons.

Epitalon, Epithalon and AEDG — how to understand the names?

Epitalon and Epithalon are alternative spellings referred to in the literature as the tetrapeptide AEDG. The spelling Epithalone is also encountered. AEDG is, however, an abbreviation of the sequence, not another name for a multicomponent preparation.

Searching for publications under different name variants can help locate related works. However, this does not exempt you from determining which material was actually used in each study.

Definition	Meaning in this article
Epitalon	Name of the tetrapeptide AEDG
Epithalon	Alternative spelling of the name of this tetrapeptide
Epithalone	An alternative variant of the name found in literature
AEDG	Single-letter sequence code
Ala-Glu-Asp-Gly	Three-letter notation of the same sequence
Epithalamin	The name of the complex peptide preparation, not the AEDG synonym

The name identifies the expected reference structure. This does not yet prove the identity of any sample so labelled.

Epitalon and Epithalamin — the most important distinction

The history of Epitalon is linked to research on Epithalamin, a preparation derived from pineal gland tissue. A 2025 historical review describes the development of synthetic AEDG based on the amino acid composition of this material. [2]

However, a defined tetrapeptide and a peptide extract are not the same chemical entity. An extract may comprise multiple components, whereas the name of a single sequence indicates a specific molecular unit.

Therefore, information from the paper on Epithalamin does not automatically become information about purified AEDG. One must first check the material description, its composition and the scope of identification.

A historical connection also does not justify calling every modern sample of Epitalon a „pineal gland extract”. The synthetic production of the peptide and the isolation of biological material are distinct processes.

What does the term „synthetic tetrapeptide” mean?

„Synthetic” describes the way a compound is obtained via chemical reactions. „Tetrapeptide” means a peptide containing four amino acid residues.

None of these terms constitutes an independent analytical result. The synthesis may be directed towards a specific structure, but its achievement must be confirmed. In turn, the number of four residues is not sufficient to distinguish all tetrapeptides.

Nor should a short sequence be equated with the simplicity of every chemical issue. Even a small peptide can exist as various isomers, derivatives or material forms.

Epitalon amino acid sequence

The AEDG sequence is read from the amino, N, terminus to the carboxyl, C, terminus. Successive letters correspond to the residues shown in the table.

Position	Single-letter code	Three-letter code	Amino acid
1	A	Wing	Alanine
2	E	Glu	Glutamic acid
3	D	Asp	Aspartic acid
4	G	Gly	Glycine

In this notation E stands for glutamic acid and D for aspartic acid. They should not be confused with glutamine, denoted by Q, and asparagine, denoted by N. These are different amino acid residues. The rules for amino acid symbology are described by the IUPAC–IUB nomenclature. [3]

Sequence is part of the peptide's identity. AEDG is not an arbitrary list of four components.

Amino acid composition and sequence of residues

The amino acid composition indicates which residues are present and how many of each kind there are. In AEDG, each of the four listed residues is present once.

The sequence contains additional information: it establishes their order. A different arrangement of the same residues can yield a different peptide while maintaining the same elemental composition and mass.

Therefore, composition analysis does not replace full sequence determination. The consistency of the amino acid list with expectations provides narrower information than confirming their order and method of linkage.

How does an amino acid residue differ from a free amino acid?

An amino acid residue is the part of an amino acid incorporated into the structure of a peptide. It is not an independent molecule floating alongside the other components.

In the basic linear structure, four residues are linked by three peptide bonds. When calculating the formula of the product from the formulae of the four free amino acids, the formal subtraction of three water molecules is taken into account.

This is a structural balance, not a description of every possible synthesis method. Actual laboratory reactions may use protecting groups and activated derivatives, which the simplified balance does not show.

N and C termini and the notation H-Ala-Glu-Asp-Gly-OH

In the standard unmodified structure, the N-terminus is at the alanine residue and the C-terminus is at the glycine residue. The notation H-Ala-Glu-Asp-Gly-OH emphasises the absence of an additional covalent block on both termini.

This does not mean that the end groups retain one unchanging protonation state under all conditions. Sequence notation and ionisation description represent different features.

C-terminal amidation or N-terminal acetylation would constitute structural modifications. Such a derivative should not be treated as the same unmodified molecule merely because the sequence of letters AEDG has been preserved.

Bonds in the backbone and side chains

In the basic structure of Epitalon, peptide bonds connect successive residues via groups bonded to the α-amino acid backbone. Glu and Asp additionally contain side-chain carboxyl groups.

The presence of an extra carboxy group does not mean that it is the one forming a bond with the next residue. The point of attachment must be read from the structure.

If the bond were routed through the side chain, the connectivity of the atoms would change. Such a variant would require a separate description, even if it contained the same types of amino acids.

In the older representations discussed in the supplied material, there were ambiguities concerning such connections. In this article, the standard linear AEDG remains the point of reference; we do not treat the different drawing as a confirmed synonym for this structure.

Is Epitalon always a straight line in space?

„Linear” describes the way the residues are linked and the absence of a closed main chain into a ring. It does not imply a rigid, permanently straightened shape.

A peptide can adopt various conformations. These depend on intra-molecular interactions and its environment.

A drawing of an extended sequence, a computer model and an experimentally determined structure are not the same kind of information. An explanatory graphic does not establish a single universal conformation for all conditions.

Stereochemistry of AEDG and the special role of glycine

In the standard description of Epitalon, alanine, glutamic acid and aspartic acid have the L configuration. Glycine is achiral: its $\alpha$-carbon atom has two hydrogen atoms attached, which is why it is not assigned an L or D designation. [1,4]

Changing the configuration of one of the chiral residues leads to a different stereoisomer. It may have the same mass and empirical formula as the starting structure.

The letter D in the AEDG sequence should not be confused with the prefix D describing configuration. In the sequence, D denotes an aspartic acid residue. Stereochemical information requires a different notation and appropriate context.

Empirical formula and molar mass

The empirical formula of unmodified Epitalon is C₁₄H₂₂N₄O₉. Its molar mass is approximately 390.35 g/mol. The PubChem record for this structure has the CID 219042. [1]

The formula can be checked by the balance of four free amino acids:

Balance sheet item	Pattern
Alanine	C₃H₇NO₂
Glutamic acid	C₅H₉NO₄
Aspartic acid	C₄H₇NO₄
Glycine	C₂H₅NO₂
Amount before formal water subtraction	C₁₄H₂₈N₄O₁₂
Subtraction of 3 H₂O for three peptide bonds	C₁₄H₂₂N₄O₉

This balance does not confirm the order of the residues. Another sequence built from the same four amino acids can have an identical pattern.

Molar mass, monoisotopic mass and m/z

The molar mass expressed in g/mol and the monoisotopic mass are not names of the same quantity. The former is sometimes calculated taking into account average atomic masses, while the latter refers to a specific set of isotopes.

A mass spectrometer records the mass-to-charge ratio of an ion, m/z. An ion can be formed by protonation, deprotonation or adduct formation. Its signal should not be directly equated with the rounded molar mass of the neutral molecule.

Therefore, comparing documents requires checking what magnitude was given. An apparent difference in numbers does not necessarily mean a structural inconsistency, but neither does a similar number constitute full proof of identity.

Ionisation and the term „free base”

AEDG has an amino group and carboxyl groups, including the side groups of Glu and Asp. Their protonation depends on conditions, especially pH.

For this reason, generally referring to any form without a specified counterion as a „free base” lacks precision. It does not fully describe a peptide containing both acidic and basic groups simultaneously.

In the documentation, it is better to specify the exact chemical form or note that the unmodified peptide structure is being discussed. Without data, a specific salt, degree of protonation, or composition of the bulk material should not be added.

Counter-ion and peptide modification

A counterion and a covalently attached group to a peptide are different things. The presence of acetate as a component of the material is not the same as N-acetylation of the N-terminus.

N-acetylation alters the covalent structure of the molecule. The salt form, on the other hand, relates to the ionic composition and does not in itself imply a rearrangement of residues in the sequence.

Information	What does it describe?
AEDG	Order of the remains
N-acetylated AEDG	N-terminal covalent modification
Material containing an acetate counterion	Ionic composition of the material
Hydration	The presence of water in a specified form of material
Admixture of another peptide	Additional sample component

The entire material composition cannot be derived from the name Epitalon alone. The proportion of counter-ions and water may require separate determination.

Peptide mass and total sample mass

The total mass of the sample may include peptide, water, counter-ions and other components. It is not automatically equal to the mass of the AEDG itself.

Similarly, the result expressed for the dry material does not have to be directly comparable with the result for the sample as received. The basis of calculation is part of the analytical information.

The distinction does not require discussing packaging or quantities to be used. It is a general rule for interpreting chemical composition.

Synonym, analogue, fragment and labelled peptide

A synonym is another name for the same chemical entity. An analogue is a related structure, but does not have to be identical. A fragment covers only part of the sequence.

The labelled peptide contains an additional tag, for example a fluorescent group. Labelling can alter the mass, charge and interactions of the molecule.

Therefore, the behaviour of the labelled derivative should not be equated with that of the unmodified AEDG without additional assessment. The observation of the tracer also requires establishing whether it remains bound to the complete peptide molecule.

Identity, purity and content — three questions

Identity answers the question of what relationship has been identified. Purity refers to composition in terms of the adopted method. Content determines the amount of the substance being assayed.

Question	Type of information
Does the detected ingredient correspond to AEDG?	Identity
What other ingredients were detected with the applied method?	Pollution profile
What signal contribution has been assigned to the main component?	Chromatographic purity according to the specified calculation
How many AEDGs are marked in the material?	Contents

The result for one of these questions does not replace the answer to the others. The term „confirmed peptide” is insufficient if it is not known what was actually confirmed.

What does chromatography say?

Chromatography separates components depending on their interaction with the separation system. Retention time and peak profile can support sample characterisation.

A single dominant peak does not, however, determine the full identity. Different components can co-evolve, and not all are detected with the same sensitivity.

The percentage of peak areas depends on the detector, conditions and calculation method. It does not have to be equal to the percentage mass fraction of AEDG in the entire material.

What do mass spectrometry and structural analysis contribute?

Mass spectrometry can provide information consistent with the expected ion mass and compound composition. Fragmentation analysis can support sequence determination.

This does not mean that every mass measurement will automatically distinguish all isomers or L and D configurations. The scope of identification depends on the data and the method used.

Where ambiguity concerns atom connectivity or stereochemistry, appropriately chosen additional methods may be needed, for example NMR spectroscopy or chiral analysis. There is no single number that replaces every type of characterisation.

How should peptide stability be understood?

Stability means the retention of specific characteristics under defined conditions and over time. It should be indicated whether the structure, content, impurity profile or physical properties were assessed.

The result obtained for one matrix cannot be automatically assigned to another material. Also, the terms „synthetic” or „short peptide” do not establish a shelf life.

This description does not provide dissolution or storage instructions. It only explains why the stability claim requires conditions and data, rather than following from the name itself.

Why is a shared name in publications not enough?

The work may concern an unmodified AEDG, a derivative, a mixture, an extract or a material with incomplete characterisation. First, the subject of the study must be determined.

Next, it is necessary to distinguish the type of information: analytical result, computer model, cell experiment or whole-organism observation. These are different levels of description, even if the authors use similar vocabulary.

A human cell line is not a clinical trial in participants. A docking model is not in itself experimental confirmation of binding. The result of an extract does not automatically determine the characteristics of a single tetrapeptide.

Frequently asked questions about Epitalon

What is Epitalon?

Epitalon is a tetrapeptide with the sequence AEDG. The basic description refers to a specific linear structure comprising four amino acid residues. The name does not automatically describe the composition of any given sample or all of its properties. When reading the documentation, it is important to distinguish between the reference structure, the method of preparation and the results of the analysis of the test material.

Are Epitalon and Epithalon the same peptide?

In the literature, these names are used to refer to the same tetrapeptide, AEDG. A difference in spelling does not in itself indicate a new sequence. However, additional terms relating to modification, labelling or chemical form may provide important information. Therefore, in addition to the name, the full structural description should be checked.

Is Epithalamin synonymous with Epitalon?

No. Epithalamin is the name of a complex peptide preparation historically linked to pineal extracts. Epitalon refers to a defined tetrapeptide. Their historical relationship does not remove the difference between a mixture and a single compound. Findings concerning one material should not be automatically attributed to the other.

What does AEDG mean?

AEDG represents consecutive residues of alanine, glutamic acid, aspartic acid and glycine. It is a record of the sequence from the N to the C terminus. The letters are not an arbitrary list of components. Changing their order changes the described structure, even if all four types of amino acids are still present in the same number.

Does the D in AEDG stand for D configuration?

No. In the single-letter sequence code, D stands for aspartic acid. The stereochemical prefix D performs a different function and requires appropriate notation. Confusing these meanings can lead to an erroneous structural description. In the basic AEDG, the Asp residue has the L configuration.

Do all residues in Epitalon have the L-configuration?

Alanine, glutamic acid and aspartic acid in their standard structure have the L-configuration. Glycine is achiral, therefore it is not assigned the L- or D-configuration. The formulation „four L-amino acids” would be imprecise in this case. Stereochemistry should be described taking into account the structure of each residue.

How many peptide bonds does the basic AEDG contain?

A linear tetrapeptide contains three bonds linking four consecutive residues. This is information about the basic backbone. The number of bonds should not be equated with a full description of the structure, as the sequence, connection sites, configuration and terminal groups are also important. Four residues do not mean four connections in an open chain.

Does a linear peptide always have a straight shape?

No. Linearity refers to the connection of residues into an open chain. Conformation describes its spatial arrangement and can change. The drawing of a simple chain helps to show the sequence, but it does not prove that the molecule retains such a shape in solution or in any other situation.

Does the same mass mean the same sequence?

No. Rearranging the same residues can leave the pattern and mass unchanged. Stereochemical differences also do not necessarily change the mass. A matching mass signal supports identification, but its significance depends on the remaining data. It does not automatically replace the determination of sequence, configuration or atom connectivity.

Do acetate and acetylation mean the same thing?

No. Acetate can act as a counterion or an additional component of the material. Acetylation means the covalent attachment of an acetyl group at a specific site. These are distinct chemical situations. In the description of AEDG, they need to be separated because only the latter directly modifies the peptide structure in the sense discussed.

Is labelled Epitalon identical to unlabelled Epitalon?

The addition of a label alters the structure of the analysed molecule. It may also affect its behaviour. Therefore, the results obtained for the labelled derivative require interpretation that takes this modification into account. The mere detection of the label signal does not always determine whether the full, unmodified peptide or the material resulting from its transformation was observed.

Does high chromatographic purity define the whole sample?

A chromatographic result describes what was detected and calculated using a given method. It does not necessarily account for water, counter-ions, or components invisible to the detector used. Nor is it standalone confirmation of all structural details. Identity, impurity profile and assay should be interpreted as separate pieces of information.

Does synthesis confirm the quality of the peptide?

A synthesis describes the method of obtaining a material with a specific structure. It is not the result of a quality test. Confirmation of the identity and characterisation of the constituents require data relating to a specific sample. Nor does the name of the process determine stability or other properties, which must be assessed separately under appropriate conditions.

Does the chemical description confirm the biological application?

A structural description answers the question of a compound’s structure. It does not, in itself, determine its behaviour in every model or its effect in humans. Sequence, mass and analytical identity are the foundations of proper documentation, but they do not replace studies that address other questions. The scope of the conclusion should remain consistent with the scope of the data.

Disclaimer

This article is for educational and scientific-information purposes only and does not constitute medical advice, a diagnosis, therapeutic guidelines, or a recommendation for the use of Epitalon. Epitalon/Epithalon (AEDG; Ala-Glu-Asp-Gly) remains an experimental peptide. The article is educational in nature and concerns the nomenclature, history, and chemical characteristics of Epitalon. It does not constitute medical advice, a purchase recommendation, or instructions for the preparation, dosage, administration, or use of peptides. Confirmation of structure or purity is not proof of safety or efficacy in humans. The text does not evaluate the legal status of specific products.

References

[1] NCBI, PubChem. Epitalon, CID 219042. Epitalon structural record. The record was used to identify the reference structure; the formula balance presented in the text is a calculation based on sequence composition.

[2] Araj, S. K., Brzezik, J., Mądra-Gackowska, K., & Szeleszczuk, Ł. (2025). Overview of Epitalon—a highly bioactive pineal tetrapeptide with promising properties. International Journal of Molecular Sciences, 26(6), 2691. Review used for historical context and name differentiation. The bibliographic title has been kept in its original form; claims of benefits have not been transferred from it.

[3] IUPAC–IUB Joint Commission on Biochemical Nomenclature. Nomenclature and Symbolism for Amino Acids and Peptides. Names of amino acids and the basis of nomenclature.

[4] IUPAC–IUB Joint Commission on Biochemical Nomenclature. Nomenclature and Symbolism for Amino Acids and Peptides, sections 3AA-3 to 3AA-5. L/D configuration and achirality of glycine.